COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices
Join your dermatology colleagues and thought leaders as we examine the hidden impact of COVID-19 on dermatologists and providers, including new and small private practices, emotional wellbeing and the evolving priorities placed on providers during the global coronavirus pandemic. Panelists will discuss their first-hand, personal experience living with COVID-19 and ways it has impacted their physical and emotional health, practice and personal life.
Discussion and guidance will be given on simple steps you can take in the wellness sphere, crisis management and return to practice concepts for both large and small dermatology practices.
Moderators
- Richard G. Fried, MD, PhD (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)
Panelists
- Evan Rieder, MD (Board Certified Dermatologist & Psychiatrist, NYU Langone Health)
- Paul Jarrod Frank, MD (Chief Medical Officer & Founder, PFRANKMD)
- Melissa Kanchanapoomi Levin, MD (Founder, Entière Dermatology)
You May Also Like
Cell-Free Blood Cell Secretome (BCS) Counteracts Skin Aging and Restores Firmness and Elasticity
Cell-Free Blood Cell Secretome (BCS) Counteracts Skin Aging and Restores Firmness and Elasticity
From the Vault: Prospective single arm study reports sustained gains in firmness and hydration after cell free autologous injections We pulled this article from the JDD vault. A prospective, single…
Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations
Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations
Rethinking Hydroquinone: A JDD Review Every Dermatologist Should See Did you catch the latest JDD review on hydroquinone? This concise review revisits hydroquinone’s place in treating hyperpigmentation, examining its clinical…






